Heterocyclic compounds as Raf kinase modulators

Details for Australian Patent Application No. 2008262310 (hide)

Owner Amgen Inc.

Inventors Liu, Gang; Doherty, Elizabeth M.; Huang, Qi; Smith, Adrian L.

Agent Shelston IP

Pub. Number AU-A-2008262310

PCT Pub. Number WO2008/153947

Priority 60/933,911 07.06.07 US

Filing date 5 June 2008

Wipo publication date 18 December 2008

International Classifications

C07D 473/00 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/52 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

17 December 2009 PCT application entered the National Phase

  PCT publication WO2008/153947 Priority application(s): WO2008/153947

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008262317-Flip open package with tiered compartments

2008262309-Combined cycle power plant